×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1: What’s New and What’s Hot: Perspective on Pharmacovigilance and Risk Management, A Global Perspective
Session Chair(s)
Marc Poitras, PhD, MBA
Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada
In this session, representatives from regulatory agencies MHRA, FDA, and Health Canada will discuss the progress of the implementation of new/ongoing national and international initiatives to strengthen pharmacovigilance and risk management activities.
Learning Objective : At the conclusion of this session, participants should be able to:- Discuss a global understanding of the challenges faced and the solutions proposed to address them
Speaker(s)
Speaker
Mick Foy
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Director of Delivery
Speaker
Marc Mes
Health Canada, Canada
Director General, Marketed Health Products Directorate
Speaker
Robert Ball, MD, MPH, MSc
FDA, United States
Deputy Director, Office of Surveillance and Epidemiology, CDER
Have an account?